In this editorial from Biomarkers in Medicine, discover how axonal transporter proteins may be utilized as biomarkers for a variety of neurological disorders.
Browsing: emerging therapies
Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer’s disease
Discover how transcranial stimulation may be used as a therapy for cognitive impairment and Alzheimer’s disease in this review article from Neurodegenerative Disease Management
Alzheimer’s Society give us a round-up of their dementia research highlights from 2017.
Discover the emerging field of biomaterials in regenerative strategies for spinal cord injury in this editorial Future Science OA.
Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy
Preliminary findings suggest that some cell therapies may be relatively safe and effective, but larger double-blinded placebo-controlled studies are needed to establish the long-term risks and benefits.
This article discusses two potential neural networks, the serotonergic system and the OTergic system, that could prove to be particularly useful targets for endocrine therapy.
Researchers have demonstrated that the enzymatic activity of R5 receptor-type protein tyrosine phosphatases is a requisite for the maintenance of stem cell properties and tumorigenicity in glioblastoma cells and could be a promising drug target for treatment.
Researchers have identified a novel mechanism by which cells die in Alzheimer’s disease, which my aid future therapies targeting cell loss in the brain.
Recent findings suggest that there may be an association between the long-term complaints suffered after multiple concussive brain injury and synaptic nerve cell damage.
Study indicates deep brain stimulation can alleviate the long-term symptoms for patients suffering from treatment-resistant depression.